Radical Prostatectomy for Locally Advanced Prostate Cancer: Current Status

Urology

Volumn 86, Issue 1, 2015, Pages 10-15

  Faria, Eliney F ^a   Chapin, Brian F ^b   Muller, Roberto L ^a   Machado, Roberto D ^a   Reis, Rodolfo B ^c   Matin, Surena F ^b  

^a BARRETOS CANCER HOSPITAL   (Brazil)

^b UNIVERSITY OF TEXAS   (United States)

^c UNIVERSITY OF RIBEIRÃO PRETO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED CANCER; CANCER ADJUVANT THERAPY; CANCER PALLIATIVE THERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; GOLD STANDARD; HUMAN; LOCALLY ADVANCED PROSTATE CANCER; LYMPH NODE; LYMPH NODE DISSECTION; MALE; META ANALYSIS; NOMOGRAM; PHASE 2 CLINICAL TRIAL (TOPIC); PRACTICE GUIDELINE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SALVAGE THERAPY; SURGEON; SYSTEMIC THERAPY; PATHOLOGY; PROCEDURES; PROSTATIC NEOPLASMS;

HUMANS; MALE; NEOPLASM STAGING; PROSTATECTOMY; PROSTATIC NEOPLASMS;

EID: 84937512946     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2015.03.012     Document Type: Review

References (50)

1. J.I. Epstein, W.C. Allsbrook Jr., M.B. Amin, and et al. The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma Am J Surg Pathol 29 2005 1228 1242
2. M.M. Center, A. Jemal, J. Lortet-Tieulent, and et al. International variation in prostate cancer incidence and mortality rates Eur Urol 61 2012 1079 1092
3. E.F. Faria, G.F. Carvalhal, R.A. Vieira, and et al. Comparison of clinical and pathologic findings of prostate cancers detected through screening versus conventional referral in Brazil Clin Genitourin Cancer 9 2011 104 108
4. W.T. Lowrance, E.B. Elkin, D.S. Yee, and et al. Locally advanced prostate cancer: a population-based study of treatment patterns BJU Int 109 2012 1309 1314
5. A.V. D'Amico, D. Schultz, M. Loffredo, and et al. Biochemical outcome following external beam radiation therapy with or without androgen suppression therapy for clinically localized prostate cancer JAMA 284 2000 1280 1283
6. H. Van Poppel, K. Vekemans, L. Da Pozzo, and et al. Radical prostatectomy for locally advanced prostate cancer: results of a feasibility study (EORTC 30001) Eur J Cancer 42 2006 1062 1067
7. J.F. Ward, J.M. Slezak, M.L. Blute, and et al. Radical prostatectomy for clinically advanced (cT3) prostate cancer since the advent of prostate-specific antigen testing: 15-year outcome BJU Int 95 2005 751 756
8. T.D. Denberg, L.M. Glode, J.F. Steiner, and et al. Trends and predictors of aggressive therapy for clinical locally advanced prostate carcinoma BJU Int 98 2006 335 340
9. K.A. Touijer, C.R. Mazzola, D.D. Sjoberg, and et al. Long-term outcomes of patients with lymph node metastasis treated with radical prostatectomy without adjuvant androgen-deprivation therapy Eur Urol 65 2014 20 25
10. J.L. Mohler, A.J. Armstrong, R.R. Bahnson, and et al. Prostate cancer, version 3.2012: featured updates to the NCCN guidelines J Natl Compr Canc Netw 10 2012 1081 1087
11. A. Heidenreich, P.J. Bastian, J. Bellmunt, and et al. EAU Guidelines on prostate cancer. Part II: treatment of advanced, relapsing, and castration-resistant prostate cancer Eur Urol 65 2014 467 479
12. B. Turkbey, P.S. Albert, K. Kurdziel, and et al. Imaging localized prostate cancer: current approaches and new developments AJR Am J Roentgenol 192 2009 1471 1480
13. F. Pinto, A. Totaro, G. Palermo, and et al. Imaging in prostate cancer staging: present role and future perspectives Urol Int 88 2012 125 136
14. B. Desai, M.E. Gross, and H. Jadvar Multimodality imaging in biochemical recurrence of prostate cancer: utility of (18)F-NaF PET/CT in early detection of metastasis Rev Esp Med Nucl Imagen Mol 31 2012 231 232
15. P.J. Koo, and E. David Crawford (1)(8)F-NaF PRT/CT and (1)(1)C-choline PET/CT for the initial detection of metastatic disease in prostate cancer: overview and potential utilization Oncology 28 2014 1057 1062 1064-1055
16. S.F. Shariat, P.I. Karakiewicz, C.G. Roehrborn, and et al. An updated catalog of prostate cancer predictive tools Cancer 113 2008 3075 3099
17. A. Briganti, S. Joniau, P. Gontero, and et al. Identifying the best candidate for radical prostatectomy among patients with high-risk prostate cancer Eur Urol 61 2012 584 592
18. M. Roumiguie, J.B. Beauval, T. Filleron, and et al. External validation of the Briganti nomogram to estimate the probability of specimen-confined disease in patients with high-risk prostate cancer BJU Int 114 2014 E113 119
19. R.R. Allison, A. Schulsinger, V. Vongtama, and et al. If you 'watch and wait,' prostate cancer may progress dramatically Int J Radiat Oncol Biol Phys 39 1997 1019 1023
20. O. Akre, H. Garmo, J. Adolfsson, and et al. Mortality among men with locally advanced prostate cancer managed with noncurative intent: a nationwide study in PCBaSe Sweden Eur Urol 60 2011 554 563
21. C.R. Mitchell, S.A. Boorjian, E.C. Umbreit, and et al. 20-year survival after radical prostatectomy as initial treatment for cT3 prostate cancer BJU Int 110 2012 1709 1713
22. A. Vickers, C. Bennette, G. Steineck, and et al. Individualized estimation of the benefit of radical prostatectomy from the Scandinavian Prostate Cancer Group randomized trial Eur Urol 62 2012 204 209
23. M.J. Zelefsky, J.A. Eastham, A.M. Cronin, and et al. Metastasis after radical prostatectomy or external beam radiotherapy for patients with clinically localized prostate cancer: a comparison of clinical cohorts adjusted for case mix J Clin Oncol 28 2010 1508 1513
24. M.R. Cooperberg, J.M. Broering, and P.R. Carroll Time trends and local variation in primary treatment of localized prostate cancer J Clin Oncol 28 2010 1117 1123
25. J.M. Crook, G.A. Perry, S. Robertson, and et al. Routine prostate biopsies following radiotherapy for prostate cancer: results for 226 patients Urology 45 1995 624 631 discussion 631-622
26. D. Seabra, E. Faria, B. Dauster, and et al. Critical analysis of salvage radical prostatectomy in the management of radioresistant prostate cancer Int Braz J Urol 35 2009 43 48
27. D. van den Ouden, F.M. Bentvelsen, E.R. Boeve, and et al. Positive margins after radical prostatectomy: correlation with local recurrence and distant progression Br J Urol 72 1993 489 494
28. P.M. Pierorazio, J.K. Mullins, J.B. Eifler, and et al. Contemporaneous comparison of open vs minimally-invasive radical prostatectomy for high-risk prostate cancer BJU Int 112 2013 751 757
29. A.A. Vora, D. Marchalik, K.J. Kowalczyk, and et al. Robotic-assisted prostatectomy and open radical retropubic prostatectomy for locally-advanced prostate cancer: multi-institution comparison of oncologic outcomes Prostate Int 1 2013 31 36
30. S.G. Joniau, A.A. Van Baelen, C.Y. Hsu, and et al. Complications and functional results of surgery for locally advanced prostate cancer Adv Urol 2012 2012 706309
31. W.S. Ham, S.Y. Park, K.H. Rha, and et al. Robotic radical prostatectomy for patients with locally advanced prostate cancer is feasible: results of a single-institution study J Laparoendosc Adv Surg Tech A 19 2009 329 332
32. T.H. Van der Kwast, M. Bolla, H. Van Poppel, and et al. Identification of patients with prostate cancer who benefit from immediate postoperative radiotherapy: EORTC 22911 J Clin Oncol 25 2007 4178 4186
33. T. Wiegel, D. Bottke, U. Steiner, and et al. Phase III postoperative adjuvant radiotherapy after radical prostatectomy compared with radical prostatectomy alone in pT3 prostate cancer with postoperative undetectable prostate-specific antigen: ARO 96-02/AUO AP 09/95 J Clin Oncol 27 2009 2924 2930
34. G.P. Swanson, M.A. Hussey, C.M. Tangen, and et al. Predominant treatment failure in postprostatectomy patients is local: analysis of patterns of treatment failure in SWOG 8794 J Clin Oncol 25 2007 2225 2229
35. T. Daly, B.E. Hickey, M. Lehman, and et al. Adjuvant radiotherapy following radical prostatectomy for prostate cancer Cochrane Database Syst Rev 2011 CD007234
36. A. Briganti, R.J. Karnes, L.F. Da Pozzo, and et al. Combination of adjuvant hormonal and radiation therapy significantly prolongs survival of patients with pT2-4 pN+ prostate cancer: results of a matched analysis Eur Urol 59 2011 832 840
37. P. Castellucci, F. Ceci, T. Graziani, and et al. Early biochemical relapse after radical prostatectomy: which prostate cancer patients may benefit from a restaging 11C-Choline PET/CT scan before salvage radiation therapy? J Nucl Med 55 2014 1424 1429
38. S.J. Freedland, R.B. Rumble, A. Finelli, and et al. Adjuvant and salvage radiotherapy after prostatectomy: American Society of Clinical Oncology clinical practice guideline endorsement J Clin Oncol 32 2014 3892 3898
39. B.R. Viers, W.R. Sukov, M.T. Gettman, and et al. Primary Gleason grade 4 at the positive margin is associated with metastasis and death among patients with Gleason 7 prostate cancer undergoing radical prostatectomy Eur Urol 66 2014 1116 1124
40. R.L. Tomlinson, D.P. Currie, and W.H. Boyce Radical prostatectomy: palliation for stage C carcinoma of the prostate J Urol 117 1977 85 87
41. L.R. Wiegand, M. Hernandez, L.L. Pisters, and et al. Surgical management of lymph-node-positive prostate cancer: improves symptomatic control BJU Int 107 2011 1238 1242
42. B. Lennernas, K. Majumder, J.E. Damber, and et al. Radical prostatectomy versus high-dose irradiation in localized/locally advanced prostate cancer: a Swedish multicenter randomized trial with patient-reported outcomes Acta Oncologica 2014 1 7
43. A. Briganti, J.R. Karnes, L.F. Da Pozzo, and et al. Two positive nodes represent a significant cut-off value for cancer specific survival in patients with node positive prostate cancer. A new proposal based on a two-institution experience on 703 consecutive N+ patients treated with radical prostatectomy, extended pelvic lymph node dissection and adjuvant therapy Eur Urol 55 2009 261 270
44. J. Engel, P.J. Bastian, H. Baur, and et al. Survival benefit of radical prostatectomy in lymph node-positive patients with prostate cancer Eur Urol 57 2010 754 761
45. E.M. Messing, J. Manola, M. Sarosdy, and et al. Immediate hormonal therapy compared with observation after radical prostatectomy and pelvic lymphadenectomy in men with node-positive prostate cancer N Engl J Med 341 1999 1781 1788
46. K. Weingartner, A. Ramaswamy, A. Bittinger, and et al. Anatomical basis for pelvic lymphadenectomy in prostate cancer: results of an autopsy study and implications for the clinic J Urol 156 1996 1969 1971
47. T.J. Bivalacqua, P.M. Pierorazio, M.A. Gorin, and et al. Anatomic extent of pelvic lymph node dissection: impact on long-term cancer-specific outcomes in men with positive lymph nodes at time of radical prostatectomy Urology 82 2013 653 658
48. R.J. Karnes, C.R. Murphy, E.J. Bergstralh, and et al. Salvage lymph node dissection for prostate cancer nodal recurrence detected by 11C-choline positron emission tomography/computerized tomography J Urol 193 2015 111 116
49. M.D. Shelley, S. Kumar, T. Wilt, and et al. A systematic review and meta-analysis of randomised trials of neo-adjuvant hormone therapy for localised and locally advanced prostate carcinoma Cancer Treat Rev 35 2009 9 17
50. Taplin ME, Montgomery R, Logothetis CJ, et al. Effect of neoadjuvant abiraterone acetate (AA) plus leuprolide acetate (LHRHa) on PSA, pathological complete response (pCR), and near pCR in localized high-risk prostate cancer (LHRPC): results of a randomized phase II study. J Clin Oncol, 2012 ASCO Annual Meeting Abstracts. 2012;15(suppl):4521.